BioAesthetics is a pioneering company in the field of regenerative medicine, specializing in biologically derived collagen grafts for nipple reconstruction post-mastectomy. The company primarily serves breast cancer survivors who have undergone mastectomies and are seeking realistic and natural-looking nipple reconstruction. Operating in the healthcare and biotechnology market, BioAesthetics employs a business-to-business (B2B) model, partnering with hospitals, clinics, and plastic surgeons to distribute its innovative NAC (Nipple-Areolar Complex) Graft. The company generates revenue through the sale of these grafts, which are designed to integrate with the patient's body, becoming a living structure. BioAesthetics leverages cutting-edge science and commercialization strategies to bring its products to market, aiming to improve the quality of life for breast cancer survivors.

Keywords: regenerative medicine, collagen grafts, nipple reconstruction, post-mastectomy, breast cancer survivors, healthcare, biotechnology, NAC Graft, B2B model, plastic surgery.